{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:45:28Z","timestamp":1776473128566,"version":"3.51.2"},"reference-count":20,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2020,1,2]]},"DOI":"10.1080\/10428194.2019.1657575","type":"journal-article","created":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T14:25:48Z","timestamp":1569335148000},"page":"56-65","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":11,"title":["Exposure\u2013response analysis of venetoclax in combination with rituximab in patients with relapsed or refractory chronic lymphocytic leukemia: pooled results from a phase 1b study and the phase 3 MURANO study"],"prefix":"10.1080","volume":"61","author":[{"given":"Rong","family":"Deng","sequence":"first","affiliation":[{"name":"Genentech Inc, South San Francisco, CA, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonid","family":"Gibiansky","sequence":"additional","affiliation":[{"name":"QuantPharm, LLC, North Potomac, MD, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Lu","sequence":"additional","affiliation":[{"name":"Genentech Inc, South San Francisco, CA, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobin","family":"Li","sequence":"additional","affiliation":[{"name":"Genentech Inc, South San Francisco, CA, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Lu","sequence":"additional","affiliation":[{"name":"Genentech Inc, South San Francisco, CA, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunze","family":"Li","sequence":"additional","affiliation":[{"name":"Genentech Inc, South San Francisco, CA, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandhya","family":"Girish","sequence":"additional","affiliation":[{"name":"Genentech Inc, South San Francisco, CA, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jue","family":"Wang","sequence":"additional","affiliation":[{"name":"Genentech Inc, South San Francisco, CA, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Boyer","sequence":"additional","affiliation":[{"name":"F. Hoffmann \u2013 La Roche Ltd, Welwyn Garden City, UK;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noopur","family":"Shankar","sequence":"additional","affiliation":[{"name":"Genentech Inc, South San Francisco, CA, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Humphrey","sequence":"additional","affiliation":[{"name":"F. Hoffmann \u2013 La Roche Ltd, Welwyn Garden City, UK;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin J.","family":"Freise","sequence":"additional","affiliation":[{"name":"AbbVie, North Chicago, IL, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9261-1583","authenticated-orcid":false,"given":"Ahmed Hamed","family":"Salem","sequence":"additional","affiliation":[{"name":"AbbVie, North Chicago, IL, USA;"},{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Seymour","sequence":"additional","affiliation":[{"name":"Royal Melbourne Hospital, Peter MacCallum Cancer Centre, & University of Melbourne, Melbourne, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnon P.","family":"Kater","sequence":"additional","affiliation":[{"name":"Department of Hematology, Cancer Center Amsterdam, Hovon CLL Study Group, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dale","family":"Miles","sequence":"additional","affiliation":[{"name":"Genentech Inc, South San Francisco, CA, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2019,9,24]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3048"},{"key":"CIT0002","unstructured":"National Cancer Institute. 2018. 6 May. NCI Dictionary of Cancer Terms. NCI. Available from: https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/cll-sll. Accessed 2019 2 July."},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569"},{"key":"CIT0004","volume-title":"VENCLEXTA\u2122 (venetoclax) tablets, for oral use. Initial US Approval: 2016","author":"Highlights of prescribing information","year":"2019"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-016-0453-9"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1361024"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30012-8"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713976"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-016-9927-9"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.730"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.741"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.858"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13175"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2373"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-019-00788-8"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-606038"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30019-5"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1513257"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.830.830"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.715.715"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2019.1657575","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T05:45:05Z","timestamp":1598679905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2019.1657575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,24]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,2]]}},"alternative-id":["10.1080\/10428194.2019.1657575"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2019.1657575","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-03-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}